Navigation Links
CRi Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems
Date:11/26/2007

WOBURN, Mass., Nov. 26 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) announces the launch of Maestro 2 optical imaging systems in North America. The Maestro 2 received widespread acclaim at the both the recent Society of Molecular Imaging/Academy of Molecular Imaging joint conference for in vivo imaging, and at the Stanford University Small Animal Imaging Workshop as well. Maestro 2, the fully automated version of the award-winning Maestro small animal imaging system, is the ideal optical imaging system for both core imaging facilities and individual laboratories using fluorescence-based imaging methodologies.

Maestro 2 combines the sensitivity and features of the original Maestro in vivo imaging system with advanced animal handling features -- an integrated anesthesia system and temperature controlled stage and imaging chamber. Computer-controlled automation through a new, user-friendly interface provides easy zoom and focus adjustments and a rapid selection of a full range of excitation and emission filters. The Flex(TM) liquid crystal tunable filter (LCTF) provides fast, accurate spectral imaging from 500 to 950 nm, covering the full range of available in vivo fluorophores. The fully automated system allows easy instrument setup and calibration for faster, more accurate results within and between experiments. Maestro 2 provides increased sensitivity, automatic removal of autofluorescence for increase spectral contrast, and improved quantification of experimental results.

The Flex LCTF technology provides more accurate multiplexing capability and better quantification of experimental results. The software includes the Real Component Analysis(TM) (RCA) algorithm for automatic identification of spectral signatures and the Compute Spectra(TM) tool, which automatically separates combined or overlapping spectral signatures, enabling the end-user to build spectral libraries quickly and to rapidly analyze data. Quantitative measurement tools include component segmentation and regions of interest (ROI) analysis. Spatial, temporal and spectral separation of multiple signals are all enabled in the new Maestro 2, resulting in improved detection and quantification of co-localized signals in vivo.

"We are very excited about the Maestro 2 In Vivo Imaging System", says James Mansfield, Director of Multispectral Imaging Systems at CRi. "From its ergonomic design, optimized optics and user-friendly software tools, this system was designed and developed with the customers' needs in mind."

CRi, a Boston-based biomedical imaging company, has provided innovative optical imaging solutions for its customers for more than 20 years. A multidisciplinary team is dedicated to working with academic and commercial customers to provide high-value solutions. CRi provides comprehensive imaging and analysis solutions that enable the user to investigate and characterize biological phenotypes while preserving spatial context. With over 80 patents issued and pending, CRi's solution platforms encompass sub-cellular, cellular and whole animal applications. CRi's innovations are being utilized around the world to enable new breakthroughs in research, health and medicine. For more information visit our website at http://www.cri-inc.com or contact:

David Daniels, Ph.D.

Director of Marketing

CRi

35-B Cabot Road, Woburn, MA 01801 USA

Tel: 1-781-935-9099, extension 149

E-mail: ddaniels@cri-inc.com


'/>"/>
SOURCE Cambridge Research & Instrumentation, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... annual Inventors Recognition Reception at Purdue Research Park of West Lafayette, ... in recognition of outstanding contributions to, and success with, commercializing discoveries from Purdue ...
(Date:2/23/2017)... and SAN FRANCISCO , Feb. ... regenerative medicine company, and Beyond Type 1, a not-for-profit ... 1 diabetes, today announced a grant from Beyond Type ... cure for type 1 and other insulin-requiring diabetes.  ... been developing innovative stem cell-derived cell replacement therapies with ...
(Date:2/22/2017)... DIEGO , Feb. 22, 2017  PrimeVax Immuno-Oncology, ... will be presenting at the Annual Biocom Global Life ... March 2, at 11:15 AM, at the Torrey Pines ... thankful to the organizers at Biocom who have chosen ... international symposium of biotechnology companies, investors, and clinical researchers," ...
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , the leading provider of educational ... is pleased to announce the launch of a new scholarship for young scientists seeking ... This merit-based scholarship is open to all high school seniors, 17 years or older; ...
Breaking Biology Technology:
(Date:2/6/2017)... , Feb. 6, 2017 According ... security are driving border authorities to continue to ... reports there are 2143 Automated Border Control (ABC) ... currently deployed at more than 163 ports of ... 2013 to 2016 achieving a combined CAGR of ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, business ... new report, Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027 ... ... Revenues of ... for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force sensing ...
Breaking Biology News(10 mins):